In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Exact Sciences Corp. (NASDAQ: EXAS) closed at $58.38 in the last session, down -0.70% from day before closing price of $58.79. In other words, the price has decreased by -$0.70 from its previous closing price. On the day, 1.52 million shares were traded. EXAS stock price reached its highest trading level at $59.16 during the session, while it also had its lowest trading level at $57.68.
Ratios:
We take a closer look at EXAS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.17. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $75.
On June 27, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $70.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when COWARD D SCOTT sold 67 shares for $60.15 per share. The transaction valued at 4,030 led to the insider holds 44,644 shares of the business.
Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Herriott James, who serves as the SVP, General Counsel & Sec of the company, sold 30 shares for $60.15 each. As a result, the insider received 1,804 and left with 9,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 10786872320 and an Enterprise Value of 12624014336. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.13 while its Price-to-Book (P/B) ratio in mrq is 3.38. Its current Enterprise Value per Revenue stands at 4.833 whereas that against EBITDA is -183.22.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $80.56, while it has fallen to a 52-week low of $40.62. The 50-Day Moving Average of the stock is 10.44%, while the 200-Day Moving Average is calculated to be -0.66%.
Shares Statistics:
According to the various share statistics, EXAS traded on average about 2.69M shares per day over the past 3-months and 1901900 shares per day over the past 10 days. A total of 184.77M shares are outstanding, with a floating share count of 181.97M. Insiders hold about 1.51% of the company’s shares, while institutions hold 97.21% stake in the company. Shares short for EXAS as of 1723680000 were 13815277 with a Short Ratio of 5.13, compared to 1721001600 on 13979833. Therefore, it implies a Short% of Shares Outstanding of 13815277 and a Short% of Float of 7.550000399999999.
